-

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2024

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins (Paris:ERF):

ANNEXE B

Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF)
EUROFINS SCIENTIFIC SE – E1013

2. Identity of the notifier (if another person makes the notification on behalf of the issuer)
N/A

3. Total number of shares composing the share capital of the notifying issuer
192,981,183

4. Total number of voting rights attached to the shares composing the share capital of the notifying issuer, including the suspended voting rightsii
377,341,966

5. Origin of the changeiii

  • Purchase of own shares
  • Cancellation of some class A beneficiary units

6. Date when the change occurred
30 November 2024

i Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.

ii For further details on the total number of voting rights, please refer to point 1(b) of circular CSSF 08/349.

iii As, for example, a capital increase or reduction.

Contacts

Eurofins

Eurofins Scientific SE

BOURSE:ERF

Release Versions

Contacts

Eurofins

More News From Eurofins Scientific SE

Eurofins Delivers FY 2025 Objectives with a 24% EPS Growth, Accelerating Organic Revenue Growth, Margin Expansion, and Higher Free Cash Flow and Confirms Its 2027 Objectives

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review section of this press release. Financial highlights in FY 2025 Basic EPS8 grew 24% to €2.31 in 2025 vs €1.87 in 2024, driven by a strong operating performance and starting to reap the benefits from Eurofins five-year investment programme in its hub and spok...

Eurofins: Weekly Report on Share Repurchases From 19th January to 23rd January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/01/2026 FR0014000MR3 5 000 71.7101 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/01/2026 FR0014000MR3 5 000 70.5398 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 14/01/...

Eurofins CDMO Alphora Announces Development & Implementation of AI-Powered Salt and Co-Crystal Screening Software

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the development and launch of a new AI-powered software for high throughput salt and co-crystal screening – now a core component of all solid-state screening programs. Developed by Eurofins CDMO Alphora, in collaboration with a local university, this cutting-edge machine learning platform provides highly accurate predictions of salt and co-crystal formation for APIs and intermediates. This breakthrough technolog...
Back to Newsroom